by admin | Sep 26, 2023 | News & Opinions
By St. Jude Children’s Research Hospital Scientists at St. Jude found that a subset of CD8+ T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer’s disease. As many as 5.8 million Americans are currently...
by admin | Sep 25, 2023 | News & Opinions
By Lizzy Lawrence – Stat The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel...
by admin | Sep 22, 2023 | News & Opinions
By Stanford University School of Engineering – SciTech Daily When an injury occurs in many organisms, a whole-body response is triggered, possibly aiding in healing and regeneration; this is seen in mice, axolotls, zebrafish, and planarian worms. In planarians,...
by admin | Sep 21, 2023 | News & Opinions
By Kelley Luckstein – Mayo Clinic ROCHESTER, Minn. — Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers. “Five years ago, the survival rate for people with blood...
by admin | Sep 20, 2023 | News & Opinions
Noelle Alviz-Gransee – Des Moines Register Iowa Attorney General Brenna Bird sued two businesses and their owners for allegedly selling fraudulent stem cell therapy treatments to more than 250 Iowans. The lawsuit filed against Biologics Health LLC, Summit...
by admin | Sep 19, 2023 | News & Opinions
By Taylor Mixides – Drug Target Review Scientists at Stanford University have engineered a biomolecule that can specifically remove mucins from cancer cells. This breakthrough could have a significant impact on future cancer therapies. Cancer cells can elude the...
